82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
The expansion, supported by a significant UK government grant, includes a new lipid system synthesis facility and enhanced R&D capabilities
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials
Merck opens first climate-neutral manufacturing facility in Ireland
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
        Subscribe To Our Newsletter & Stay Updated